|
|
NicOx S.A.
PAR •
Healthcare •
Biotechnology •
Quote as of 06/12/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangePAR
Market Capitalization39.76 mln
Float88.13 mln
Earnings Date07/16/2025
Relative Strength
11
/ 100
Significantly lagging
Key Fundamentals
EPS-0.03
ROE-156
RPS0.19
ROIC-124
ROA-14.65
EBITDA, mln18.91
EV / EBITDA1.94
EV / EBIT68.20
Revenue, mln16.77
EV / Revenue2.19
Financial Strength
Altman Z-Score-63.74
Piotroski F-Score
5
/ 9
Beneish M-Score-4.83
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-7.35% |
6
/ 100
 |
| 1 Month |
-8.21% |
15
/ 100
 |
| 2 Months |
-23.34% |
6
/ 100
|
| 6 Months |
17.86% |
79
/ 100
 |
| 1 Year |
53.66% |
91
/ 100
 |
|
| |
